drugset / Trial / NCT01982318

A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers

NCT01982318 ↗

Phase 2/3 Withdrawn Tissue Therapies Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to assess the efficacy and safety of VitroGro® combined with standard care in the treatment of Venous Leg Ulcers (VLUs) compared to Placebo with standard care over the course of the 8-week treatment phase.

Timeline

Start
2017-01
Primary completion
2018-06
Completion
2019-06

Outcome

Outcome not reported

Stopped: “Study discontinued. Superseded by NCT02973893 VF00102.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator VitroGro® ECM Protein / enzyme biologic — Topical

Indications